between 1.7 and 2.4 percent or both for Mounjaro 10 mg and 15 mg over the period of 40 weeks. Overall, the programme demonstrated that the drug, whether used alone or with other diabetes ...

The India launch of Eli Lilly's popular weight-loss drug Mounjaro has triggered a huge wave of patient enquiries about its availability, with some Indian doctors fielding hundreds of calls about the ...

Mounjaro, a new treatment for Type 2 diabetes and obesity, has been launched in India after CDSCO approval. The drug, developed by ... Rs3,500 for a 2.5 mg vial and Rs4,375 for a 5 mg vial ...

With diabetes and obesity cases surging in India, pharmaceutical giant Eli Lilly and Company (India) has launched Mounjaro (tirzepatide), a once-weekly injectable drug ... The 2.5 mg dose is ...

Last quarter alone, its two leading GLP-1 drugs, Mounjaro and Zepbound ... patients who took the drug lost considerable weight. On average, patients who took 12 mg doses lost 11.5 lbs, or 5.8 ...